Viewing Study NCT02485028


Ignite Creation Date: 2025-12-26 @ 11:11 AM
Ignite Modification Date: 2025-12-31 @ 4:06 PM
Study NCT ID: NCT02485028
Status: COMPLETED
Last Update Posted: 2015-06-30
First Post: 2015-06-10
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Pharmacokinetic Interaction Study of Dapoxetine 30mg and Mirodenafil 50mg
Sponsor: SK Chemicals Co., Ltd.
Organization:

Study Overview

Official Title: An Open Label, Randomized, Single-dose Crossover Study to Evaluate the Pharmacokinetic Interaction of Dapoxetine 30mg and Mirodenafil 50mg in Healthy Male Volunteers
Status: COMPLETED
Status Verified Date: 2015-06
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: Healthy male volunteers were administered alone and in combination with dapoxetine 30mg mirodenafil 50mg for three times, respectively and the pharmacokinetic interaction was compared between the two drugs.
Detailed Description: None

Study Oversight

Has Oversight DMC: False
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?:

Secondary ID Infos

Secondary ID Type Domain Link View
12542 OTHER South Korea: Ministry of Food and Drug Safety View